Vertex to buy diabetes biotech firm for $950m
04-09-2019
FDA lifts hold on first human CRISPR trial
17-10-2018
CRISPR Therapeutics unites with ViaCyte to treat diabetes
19-09-2018
Vertex to acquire rights to cystic fibrosis treatment for $1.6m
09-03-2017
Vertex and CRISPR Therapeutics announce research partnership
26-10-2015